摘要
目的:研究阿托伐他汀对氧化型低密度脂蛋白(ox-LDL)诱导的人脐静脉内皮细胞(HUVECs)中Wnt信号通路及相关因子Wnt1、β-连环蛋白(β-catenin)及蓬乱蛋白1(dvl-1)表达的影响。方法:将体外培养的HUVECs分为空白对照组、ox-LDL(50 mg/L)组和低、高剂量(ox-LDL 50 mg/L+阿托伐他汀0.5、10μmol/L)组,分别加入相应药物培养24 h后,用硝酸还原酶法测定各组细胞中一氧化氮(NO)含量,用免疫组化法和蛋白质印迹法检测各组细胞中Wnt1、β-catenin及dvl-1蛋白的表达。结果:与空白对照组比较,其他3组细胞中NO含量明显减少(P<0.01),Wnt1、β-catenin、dvl-1蛋白表达均明显增强(P<0.01);与ox-LDL组比较,低、高剂量组细胞中NO含量均明显增加(P<0.01),Wnt1、β-catenin、dvl-1蛋白表达均明显减弱(P<0.01)。结论:阿托伐他汀能抑制ox-LDL诱导的HUVECs中Wnt信号通路及相关因子表达,其可能是阿托伐他汀抗动脉粥样硬化的机制之一。
OBJECTIVE: To study the effects of atorvastatin on Wnt signaling pathway and the expression of related factors Wntl, β-catenin and dvl-1 in oxidized low density lipoprotein (ox-LDL) induced human umbilical vein endothelial cells (HU- VECs). METHODS: HUVECs cultred in vitro were divided into blank control group, ox-LDL group (50 mg/L), low-dose and high-dose groups (ox-LDL 50 mg/L+atrovastatin 0.5, 10 μmol/L). They were cultured with relevant drugs for 24 h; nitrate reduc- tase method was adopted to determine the content of NO; and Wntl, β-catenin and dvl-1 protein expressions were determined by immunohistochemical method and Western blotting assay. RESULTS: Compared with blank control group, the content of NO de- creased significantly in other 3 groups (P〈0.01), while Wntl, β-catenin and dvl-1 protein expressions increased significantly (P〈 0.01) ; compared with ox-LDL group, the content of NO in ox-LDL low-dose and high-dose groups increased significantly (P〈 0.02), while Wntl, β-catenin and dvl-1 protein expressions decreased significantly (P〈0.01). CONCLUSIONS: Atorvastatin can inhibit Wnt signaling pathway and the expression of related factors in ox-LDL induced HUVECs, which may be one of anti-athero- sclerosis mechanisms of atorvastatin.
出处
《中国药房》
CAS
CSCD
2014年第17期1574-1577,共4页
China Pharmacy